CIK 0001326110
- Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 431979754
- Phone
- +1 844-696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 125,000 shares at an average $16.14 ($2,018,057)
- 4 Option exercise Director acquired 56,967 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition Executive Chairman acquired 243,212,755 shares (other)
- 4 Shares withheld for taxes Chief Executive Officer gave up 68,171 shares (to pay taxes)
- 4 Open-market sale See remarks sold 22,100 shares at $23.09 ($510,267)
- 4 Open-market sale See remarks sold 82,070 shares at $20.65 ($1,694,803)
- 4 Open-market sale See remarks sold 47,930 shares at an average $20.59 ($987,067)
Page 7 of 13 · 251 filings